D. E. Shaw & Co., Inc. Selecta Biosciences Inc Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.82 - $5.01 $201,280 - $357,593	-71,376 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.92 - $5.07 $358,015 - $621,622	-122,608 Reduced 63.21%	71,376 $323,000
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $318,133 - $663,425	193,984 New	193,984 $588,000
Q3 2020 Nov 16, 2020	SELL	$2.18 - $2.84 $274,403 - $357,479	-125,873 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.83 - $4.06 $230,347 - $511,044	125,873 New	125,873 $357,000
Q2 2019 Aug 14, 2019	SELL	$1.79 - $3.05 $54,870 - $93,494	-30,654 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.47 - $3.06 $45,061 - $93,801	30,654 New	30,654 $73,000
Q4 2017 Feb 14, 2018	SELL	$8.97 - $23.38 $110,097 - $286,966	-12,274 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.22 - $20.03 $186,810 - $245,848	12,274	12,274 $224,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.